Group 1 - The core point of the news is that Yingke Medical's stock price increased by 5.23% to 38.62 CNY per share, with a trading volume of 391 million CNY and a turnover rate of 2.25%, resulting in a total market capitalization of 25.288 billion CNY [1] - Yingke Medical, established on July 20, 2009, and listed on July 21, 2017, operates in three main business segments: personal protection (91.47% of revenue), rehabilitation care (4.75%), and other products (3.77%) [1] Group 2 - Dachen Fund has a significant holding in Yingke Medical, with its Dachen Growth Mixed Fund (160926) increasing its stake by 120,000 shares in the second quarter, bringing the total to 848,900 shares, which accounts for 3.37% of the fund's net value [2] - The Dachen Growth Mixed Fund has a current size of 449 million CNY and has achieved a year-to-date return of 26.47%, ranking 4062 out of 8166 in its category [2] Group 3 - The fund manager of Dachen Growth Mixed Fund is Zou Jian, who has been in the position for 4 years and 259 days, managing a total asset size of 1.086 billion CNY [3] - During Zou Jian's tenure, the best fund return was 12.49%, while the worst return was -21.29% [3]
英科医疗股价涨5.23%,大成基金旗下1只基金重仓,持有84.89万股浮盈赚取162.98万元